Paul is the sebior counsel and executive director of CBIA‘s Bioscience Growth Group. We take a look atthe impact of the drug price provisions in the Inflation Reduction Act.
Paul is the sebior counsel and executive director of CBIA‘s Bioscience Growth Group. We take a look atthe impact of the drug price provisions in the Inflation Reduction Act.